SAN DIEGO , July 9, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the second quarter 2026 following the close of market on Thursday, July 30, 2026....
New leaders bring extensive leadership experience across life sciences, diagnostics, and medical technology
2 Mooning Stocks Worth Investigating and 1 We Avoid
Life Sciences Tools & Services Stocks Q1 Results: Benchmarking Illumina (NASDAQ:ILMN)
1 High-Flying Stock with Solid Fundamentals and 2 We Find Risky
3 Mid-Cap Stocks That Concern Us
Why Illumina (ILMN) Stock Is Down Today
Eli Lilly and Company's Chief Scientific and Product Officer brings pharmaceutical R&D and scientific leadership perspective to Illumina's Board
1 Unpopular Stock That Deserves Some Love and 2 Facing Challenges
The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -1.62%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -1.87%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.98%. June...